NCT02871856
International Lung Screen Trial (ILST) No drug interventions screening Not Available active_not_recruiting NCT00990535
High Dose Somatostatin Analogues in Neuroendocrine Tumors treatment 2 completed NCT06177925
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC treatment 2 recruiting NCT03402048
The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial treatment 3 unknown_status NCT01039948
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT02431962
Alberta Lung Cancer Screening Program No drug interventions screening Not Available unknown_status NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT03134872
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC treatment 3 completed NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC No drug interventions Not Available Not Available unknown_status NCT04776447
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) treatment 2 active_not_recruiting NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors treatment 1 completed NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT02909452
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 completed NCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study No drug interventions Not Available Not Available not_yet_recruiting NCT06004440
Real World Registry for Use of the Ion Endoluminal System No drug interventions Not Available Not Available recruiting NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT06376084
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC No drug interventions Not Available Not Available recruiting NCT02602067
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients No drug interventions treatment 1 terminated